Department of Pathology and Research Center for Oral Disease Regulation of the Aged, School of Dentistry, Chosun University, Gwangju 501-759, Republic of Korea.
Oncol Rep. 2012 Jun;27(6):1772-8. doi: 10.3892/or.2012.1748. Epub 2012 Mar 27.
Photodynamic therapy (PDT) with several photosensitizers is a promising modality for the treatment of cancer. In this study, the therapeutic effect of PDT using the synthetic photosensitizer pheophorbide a (Pa-PDT) was examined in AT-84 murine oral squamous cell carcinoma (OSCC) cells. The MTT assay revealed that Pa-PDT induced cell growth inhibition in a dose- and time-dependent manner. Pa-PDT treatment significantly induced intracellular ROS generation, which is critical for cell death induced by Pa-PDT. Cell cycle analysis showed the increased sub-G1 proportion of cells in Pa-PDT-treated cells. Induction of apoptotic cell death was confirmed by DAPI staining and the reduction of mitochondrial membrane potential (ΔΨm) on Pa-PDT-treated cells. The changes in apoptosis-related molecules were next examined using western blotting. Cytochrome c release and cleavage of caspase-3 and PAPR were observed in AT-84 cells, whereas Bcl-2 protein levels were decreased. To determine the therapeutic effect of Pa-PDT in vivo, a murine OSCC animal model was used. Treatment of mice with Pa-PDT significantly inhibited tumor growth, especially PDT with Pa intravenous administration (i.v. Pa-PDT), and increased proliferative cell nuclear antigen (PCNA) levels and TUNEL-stained apoptotic cells compared to vehicle-treated controls. The data demonstrate that the in vitro effects of Pa-PDT on the inhibition of tumor cell proliferation and induction of apoptosis correlate to the anticancer activity of Pa-PDT in vivo. Our findings suggest the therapeutic potential of Pa-PDT in OSCC.
光动力疗法(PDT)结合几种光敏剂是治疗癌症的一种很有前途的方法。在本研究中,使用合成光敏剂原卟啉 IX(Pa-PDT)的 PDT 的治疗效果在 AT-84 鼠口腔鳞状细胞癌(OSCC)细胞中进行了检查。MTT 测定显示 Pa-PDT 以剂量和时间依赖的方式诱导细胞生长抑制。Pa-PDT 处理显著诱导细胞内 ROS 的产生,这对于 Pa-PDT 诱导的细胞死亡至关重要。细胞周期分析显示 Pa-PDT 处理的细胞中增加的亚 G1 比例。通过 DAPI 染色和线粒体膜电位(ΔΨm)的降低证实了凋亡细胞死亡的诱导。通过 Western blot 进一步检查了凋亡相关分子的变化。在 AT-84 细胞中观察到细胞色素 c 释放和 caspase-3 和 PAPR 的裂解,而 Bcl-2 蛋白水平降低。为了确定 Pa-PDT 在体内的治疗效果,使用了鼠 OSCC 动物模型。Pa-PDT 治疗显著抑制肿瘤生长,特别是 Pa 静脉内给药(i.v. Pa-PDT),与载体处理对照组相比,增殖细胞核抗原(PCNA)水平增加和 TUNEL 染色的凋亡细胞增加。数据表明,Pa-PDT 在体外对肿瘤细胞增殖抑制和诱导凋亡的作用与 Pa-PDT 在体内的抗癌活性相关。我们的研究结果表明 Pa-PDT 在 OSCC 中的治疗潜力。